Suchergebnisse - "Pavilack, Melissa"

PubPharm (10)

1

EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors

enthalten in: BMC cancer | 2020

von Chiang, A. | Fernandes, A. | Pavilack, M. | +5

2

EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors

enthalten in: BMC cancer | 2020

von Chiang, A. | Fernandes, A. | Pavilack, M. | +5

3

EGFR mutation testing and treatment decisions in patients progressing on first- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors

enthalten in: BMC cancer | 2020

von Chiang, A. | Fernandes, A. | Pavilack, M. | +5

4

Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors

enthalten in: Advances in therapy | 2020

von Nadler, E. | Pavilack, M. | Espirito, J. | +2

5

Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors

enthalten in: Advances in therapy | 2020

von Nadler, E. | Pavilack, M. | Espirito, J. | +2

6

Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors

enthalten in: Advances in therapy | 2020

von Nadler, E. | Pavilack, M. | Espirito, J. | +2

7

Observational Study of Treatment Patterns in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Non-Small Cell Lung Cancer After First-Line EGFR-Tyrosine Kinase Inhibitors

enthalten in: Advances in therapy | 2020

von Nadler, E. | Pavilack, M. | Espirito, J. | +2

8

Real-world outcomes in patients with unresected stage III non-small cell lung cancer

enthalten in: Medical oncology (Northwood, London, England) | 2019

von Ryan, K. | Skinner, K. | Fernandes, A. | +4

9

Real-world outcomes in patients with unresected stage III non-small cell lung cancer

enthalten in: Medical oncology | 2019

von Ryan, K. | Skinner, K. | Fernandes, A. | +4

10

Real-world outcomes in patients with unresected stage III non-small cell lung cancer

enthalten in: Medical oncology | 2019

von Ryan, K. | Skinner, K. | Fernandes, A. | +4

1
[1]